Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 360-365

  Gelband, Craig H ^a,b   Reaves, Phyllis Y ^a   Evans, Jenafer ^a   Wang, Hongwei ^a   Katovich, Michael J ^a   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Arterioles; Ca2 current; Calcium, intracellular; Excitation contraction coupling; Gene therapy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; DRUG EFFECT; ENZYME INHIBITION; EXCITATION CONTRACTION COUPLING; GENE THERAPY; HEART OUTPUT; HYPERTENSION; KIDNEY BLOOD FLOW; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0032929082     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.360     Document Type: Article

References (21)

1. Khalil RA, Lodge NJ, Gelband CH, van Breemen C. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Publishers; 1990:547-567.
2. Whelton PK. Epidemiology of hypertension. Lancet. 1994;334:101-106.
3. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic and cardiovascular risks: US population data. Arch Intern Med. 1993; 153:598-615.
4. Kang PM, Landau AJ, Eberhardt RT, Fishman WH. Angiotensin II receptor antagonists: a new approach to blockade of renin angiotensin system. Am Heart J. 1994;127:1388-1401.
5. Hsueh WA, Do Y-S, Anderson PW, Law RE. Angiotensin II in cell growth and matrix production. In: Mukhopadhyay A, Raizada MK, eds. Tissue Renin-Angiotensin System. New York, NY: Plenum Press; 1995: 217-223.
6. Brunner HR, Nussberger J, Waeber B. Angiotensin II blockade compared with other methods of inhibiting the renin-angiotensin system. J Hypertens. 1993;11:553-558.
7. Kurtz TW, Simonet L, Kabra PN, Wolfe S, Chen L, Hjelle BL. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest. 1990;85:1328-1332.
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Label JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
9. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension. 1994;24:63-69.
10. Kaneko K, Susic D, Nunez E, Frohlich ED. Losartan reduces cardiac mass and improves coronary flow reserves in the spontaneously hyper-tensive rat. J Hypertens. 1996;14:645-653.
11. Vogt M, Motz WH, Schwartzkopf B, Strauer BE. Pathophysiology and clinical aspects of hypertensive hypertrophy. Eur Heart J. 1993;14:2-7.
12. 1B receptors in blood pressure regulation. Am J Physiol. 1997;272: F515-F520.
13. 1-R mRNA antisense. Hypertension. 1997;29:374-380.
14. 1 receptor antisense gene therapy. Proc Natl Acad Sci U S A. 1998;95:2664-2669.
15. Martens JR, Gelband CH. Ion channels in vascular smooth muscle: alterations in essential hypertension. Proc Soc Exp Biol Med. 1998;218: 192-203.
16. Curtis J, Luke R, Dustan H, Kashgarian M, Whelchel J. Remission of essential hypertension after renal transplantation. N Engl J Med. 1983; 309:1009-1015.
17. Iyer SN, Lu D, Katovich MJ, Raizada MK. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci U S A. 1996;93:9960-9965.
18. 1 receptor antisense in neurons and SMC. Am J Physiol. 1998;274:H719-H727.
19. Lu D, Raizada MK, Iyer S, Reaves P, Yang H, Katovich MJ. Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats. Hypertension. 1997;30:363-370.
20. + channels in hypertension. Circ Res. 1996;79:295-301.
21. Liao DF, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells. Circ Res. 1996;79:1007-1014.